NOF omab hetkel AAQS väärtuseks 7. Kõrget AAQS-i võib pidada positiivseks märgiks, et ettevõte areneb edukalt. Investorid võivad eeldada, et ettevõte on heas seisus kasumi teenimiseks. Teisest küljest on oluline vaadelda NOF aktsia AAQS-i võrdluses saadud kasumite ja sama sektori teiste ettevõtetega. Kõrge AAQS ei ole absoluutne garantii positiivseks tulevikuks. Ainult nii on võimalik saada täielik ülevaade ettevõtte sooritusest. Ettevõtte arengu paremaks hindamiseks on oluline võrrelda AAQS-i sama sektori teiste ettevõtetega. Üldiselt peaksid investorid alati vaatlema ettevõtte AAQS-i seoses teiste näitajatega nagu kasum, EBIT, rahavoog ja muud, et teha põhjendatud investeerimisotsus.

NOF Aktienanalyse

Mis teeb NOF?

NOF Corporation is a Japanese company that has been operating in various industries since its establishment in 1911. It started as a manufacturer of chemicals, particularly olefinic derivatives, and soon discovered other sectors. Today, NOF Corp is a major player in the pharmaceutical, life sciences, and materials science industries. NOF Corp is headquartered in Tokyo and has branches and subsidiaries in various countries. It is listed on the Tokyo Stock Exchange and employs over 2,500 people worldwide. History: NOF Corp was founded in 1911 as a trading company specializing in the sale of chemicals. In the 1920s, the company began producing synthetic camphor, an important raw material in the fragrance and medical fields. During World War II, NOF manufactured military goods, including ammunition, aircraft components, and synthetic fibers. After the war, the company refocused on chemistry and expanded its presence in other countries, particularly in the United States and Europe. In the 1980s, NOF expanded into new industries such as advertising, marketing, and real estate. Currently, the company focuses on three main business areas: pharmaceuticals, life sciences, and materials science. Business Model: NOF Corp is a B2B company that primarily sells its products to other businesses. The company focuses on providing high-quality products tailored to the diverse needs of its customers. One of the company's principles is to constantly develop innovations to offer its customers a high level of quality and performance. NOF Corp also collaborates closely with companies and universities to advance research and development together. The company invests in research and development activities to offer innovative and effective solutions to its customers. Divisions: NOF Corp is divided into three main business segments: pharmaceuticals, life sciences, and materials science. Pharmaceuticals: NOF Corp produces a variety of pharmaceutical products, including active ingredients, intermediates, and excipients. These products are used by pharmaceutical companies worldwide to manufacture a wide range of drugs. Life Sciences: NOF Corp produces high-quality biochemicals and accessories to support cell growth in biotechnology and life sciences research. The company also manufactures polyethylene glycol-based products that are widely used in the pharmaceutical and life sciences industries. Materials Science: NOF Corp produces and supplies a range of materials, including electronic materials, polymers, separation membranes, and specialty resins. These materials are used in various industries such as electronics, automotive manufacturing, and energy supply. Products: NOF Corp offers a wide range of products, including: - Pharmaceutical active ingredients: NOF Corp manufactures active ingredients used in various medications. - Biochemicals: NOF Corp supplies chemical products used in cell culture in the life sciences industry. - Electronic materials: The company produces a range of high-tech materials used in the electronics industry. - Specialty resins: NOF Corp produces resins used in various areas such as the automotive industry and pipe manufacturing. - Separation membranes: NOF Corp offers membranes used in water treatment, wastewater treatment, and chemical separation. In summary, NOF Corp is a versatile company that manufactures a wide range of products in the pharmaceutical, life sciences, and materials science fields. The company has a long history and is committed to developing innovations to provide its customers with innovative solutions and high-quality products. NOF ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Sagedased küsimused NOF aktsia kohta

Aktsiasäästuplaanid pakuvad investoritele atraktiivset võimalust pikema aja jooksul vara koguda. Üheks peamiseks eeliseks on nn keskmise maksumuse efekt: investeerides regulaarselt kindla summa aktsiatesse või aktsiafondidesse, ostetakse automaatselt rohkem osakuid siis, kui hinnad on madalad, ja vähem, kui need on kõrged. See võib aja jooksul viia soodsama keskmise hinna per osakuni. Lisaks võimaldavad aktsiasäästuplaanid ka väikeinvestoritel pääseda ligi kallimatele aktsiatele, kuna nendega saab liituda juba väikeste summadega. Regulaarne investeerimine soodustab ka distsiplineeritud investeerimisstrateegiat ja aitab vältida emotsionaalsete otsuste, nagu impulsiivne ostmine või müümine. Peale selle saavad investorid osa aktsiate võimalikust väärtuse kasvust ning dividendide väljamaksetest, mida saab reinvesteerida, mis tugevdab intressiintressi efekti ning seeläbi investeeritud kapitali kasvu.

Andere Kennzahlen von NOF

Meie NOF Käive-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes NOF Käive. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: